{"id":1116,"createDateTime":"2025-07-28T06:19:58.189Z","archiveDateTime":"2026-12-31T09:30:00.000Z","name":"The RSV Mother and Infant Protection Program (RSV-MIPP) - A practical guide to the GP's role","image":"8e24f7ab8db2c388af3d3d9eb76e01faf266d0699093583d52bea2d6","imageThumbnail":"d14082ef53c88cb01b5a9dbf5d3edf684b745aebd75c3314fd0dadf8","about":"The Respiratory Syncytial Virus Maternal and Infant Protection Program (RSV-MIPP) has been rolled out across Australia from February 2025 to reduce the incidence of serious illness and hospitalisation due to RSV in infancy. GPs will be at the forefront of educating women and delivering maternal immunisation against RSV with Abrysvo® to ‘cocoon’ the developing baby.\n\nGPs will also be largely responsible for arranging ‘catch up’ nirsevimab (a monoclonal antibody Beyfortus™) for infants under 2 years at high risk or whose mothers either missed out on immunisation or were immunised within two weeks of delivery. While maternal immunisation is covered under the NIP, nirsevimab is state funded so all states differ in their approach to the rollout.\n\nParticipants will determine safe and effective maternal immunisation against RSV as well as be able to describe eligibility, dosage and indications for nirsevimab administration applicable to where they work in Australia.\n\n**Learning Outcomes**\n1. Describe RSV immunisation of pregnant women under the NIP to best cocoon their baby against RSV once born.\n2. List the indications for nirsevimab in infants born from the advent of the RSV-MIPP onwards across Australia\n3. List the indications for catch-up nirsevimab in infants born before advent of RSV-MIPP and approaching their first RSV season across Australia.\n4. List the indications for catch-up nirsevimab in infants born before advent of RSV-MIPP and approaching their second RSV season across Australia.\n5. Determine correct dose of nirsevimab for eligible infants as above.\n6. Describe how practice systems can aid in identifying and recalling pregnant women for RSV immunisation and eligible infants as above for nirsevimab.\n7. Determine the resources and correct information for the RSV-MIPP according to the state you work in.\n\n**This activity has a pre-activity Reviewing Performance available by clicking the RP button above**\n\nFind state government RSV resources and other helpful links from the video below.\n\nYou can access more RSV education on Praxhub [here](https://app.praxhub.com/orgs/sanofi-49/education).\n\n**Provider**\nThe Provider of this activity is [Praxhub](https://app.praxhub.com/orgs/1). Praxhub is an authorised Provider of education under the RACGP CPD Program. For any questions regarding this webinar please contact support@praxhub.com.","type":"video","summaryViewCount":2962,"startDateTime":null,"durationSecs":4467,"endDateTime":null,"organisation":{"id":49,"name":"Sanofi","logoImage":"377a096c12d92fe7ee15f77f79bd213355e6a8242aba00bb5bbfa06c","logoImageThumbnail":"bf9e50abda0b69fb205163c747cb5ad3eb67393934ccb177149763f4","industry":"Pharmaceutical"},"provider":{"id":1,"name":"Praxhub","logoImage":"7d8c82e84cfeb7556fa842c1980c93b8144ab0959b0630c17e557baf","logoImageThumbnail":"78ba1e568155afb45aa67fc6f7337c076b0a1aa9182ceb80ac9b1095","industry":"Health Technology"},"commentCount":2,"likeCount":31,"presenters":[{"id":58307,"specialty":{"id":94,"name":"General Practice"},"name":"Dr Cath Beasley","title":null,"profileImage":"217569d8d9bcef2955217cb440e82a261a7fac214b5b2223d0da41a9","profileImageThumbnail":"2a0dcba647f1d8f21cbfdf231716ccb45d0ddd1426c3eb86b58b5b53"},{"id":61818,"specialty":{"id":61,"name":"Infectious Diseases"},"name":"Jim Buttery","title":"Infectious Diseases Physician","profileImage":"0cdc23ef13e1720665df38719fa5cba5c37ebaf645e7ba0802c0d119","profileImageThumbnail":"9419fcbf87090b9add89489c0d94afe4f61e9600f8ef86e7c031762a"}],"relatedEducation":[{"id":1320,"name":"The Long Shadow of RSV: Infection, Airway Injury, and Lifetime Asthma Risk","image":"36a4654db6ce52fa8a2d7b6dedee82145a807b10064bb2944c3ed46b","imageThumbnail":"946218c60a8ed5b756c2f981eb9bcbc2e38772a1b8e63fd829567ce7","type":"video","startDateTime":null,"durationSecs":5185,"associationEducationTypes":["EA","MO","RP"],"organisation":{"id":49,"name":"Sanofi"}},{"id":1124,"name":"The Maternal and Child Health Nurse's Role in RSV Counselling: A Case Study","image":"b1d4288730ebe7dac9702bc25a910e96c53109a37f974e24980d9ae7","imageThumbnail":"2217e33d4fa808f4f1968e7556f4b2267c426987dd88261caba9afe6","type":"video","startDateTime":null,"durationSecs":383,"associationEducationTypes":[],"organisation":{"id":49,"name":"Sanofi"}},{"id":1123,"name":"The Midwife's Role in RSV Counselling: A Case Study","image":"e874356d96cbb39fd0ccc58b88bded5a4329b3eaf1f3188c13fbd1ae","imageThumbnail":"64da5684709ea73cff23eae734c4b30c7c49e9271c8979ce579d6448","type":"video","startDateTime":null,"durationSecs":372,"associationEducationTypes":[],"organisation":{"id":49,"name":"Sanofi"}},{"id":1016,"name":"Bronchiolitis","image":"f86abafedb8c91766a240a357166c2be65511e3d0fdfecf0cdf9c242","imageThumbnail":"e470c5bdea50d6dfa90dcfa7fe29203cb2dc8d33d59e308edacd4f9c","type":"rise-scorm-2004-4","startDateTime":null,"durationSecs":1800,"associationEducationTypes":["EA","RP"],"organisation":{"id":49,"name":"Sanofi"}},{"id":1015,"name":"Understanding RSV","image":"a92d63d3faba56024204715e608f61452fd33338dfef15a5d7cfa99d","imageThumbnail":"0371509fd42a7423287be4522ce92390fd749c343c3cfe3ba8d85ade","type":"rise-scorm-2004-4","startDateTime":null,"durationSecs":1800,"associationEducationTypes":["EA","MO"],"organisation":{"id":49,"name":"Sanofi"}},{"id":1014,"name":"The many guises of infant & pre-schooler cough","image":"819838865251cc8def84cb484f14e52379fd4da7f84e0bfa1e1e9e33","imageThumbnail":"4dd71c351f8a11df0b8cd162d15f11ee33ffb13c9be6aadd68753530","type":"video","startDateTime":null,"durationSecs":3535,"associationEducationTypes":["EA","RP"],"organisation":{"id":49,"name":"Sanofi"}}]}